Table 6. | Treatment outcomes reported in the included studies |
Author | Type of surgery | Graft description | Type of result measurement | Outcomes | Complications |
---|---|---|---|---|---|
Schwarz et al. [19] | Lateral alveolar; ridge augmentation | Tooth root (block) | CBCT |
-Gain in ridge width: tooth root 5.53 (SD 1.88) mm; bone 3.93 (SD 1.41) mm; P = 0.014 -Graft resorption: tooth root 0.13 (SD 0.97) mm; bone 1.03 (SD 1.15) mm; P = 0.029 |
In both groups after 26 weeks screw head was exposed in one patient, but not associated with any signs of wound infection |
Pang et al. [31] | Alveolar bone augmentation | Autogenous demineralized dentin (particulate) | Resin templates and periodontal probe, histomorphometric analysis, "Osstell™ ISQ" tool for implant stability |
-Vertical bone gain: DDM 5.38 (SD 2.65) mm; Bio-Oss® 6.56 (SD 3.54) mm; P = 0.337 -Percentage of newly formed bone: DDM 31.24 (SD 13.87)%; Bio-Oss® 35 (SD 19.33)%; P = 0.606 -Percentage of residual graft material. DDM 8.95 (SD 6.15)%; Bio-Oss® 17.08 (SD 16.57)%; P = 0.245 -ISQ: DDM 72.8 (SD 10.81); Bio-Oss® 70 (SD 12.86); P = 0.755 |
No registered complications |
Li et al. [32] | Alveolar bone augmentation | Autogenous demineralized dentin (particulate) + membrane + PRF | Panoramic and periapical radiography, "Osstell™ ISQ" tool for implant stability |
- ISQ: After surgery: Bio-Oss® 54.1 (SD 13); DDM 53.6 (SD 11.9); P = 0.14 After 6 months: Bio-Oss® 78.1 (SD 4.2); DDM 77.6 (SD 7.9); P = 0.11 After 18 months: Bio-Oss® 80.2 (SD 4.3); DDM 79.5 (SD 6); P = 0.09 - Marginal bone resorption: After 6 months: Bio-Oss® 1.8 (SD 0.1) mm; DDM 1.7 (SD 0.3) mm; P = 0.25 After 18 months: Bio-Oss® 2 (SD 0.5) mm; DDM 1.9 (SD 0.6) mm; P = 0.18 |
Failed osseointegration and infection in one implant in both groups |
Santos et al. [33] | Alveolar ridge preservation | Autogenous mineralized dentin (particulate) | CBCT, periapical radiography, histomorphometric analysis, "Osstell™ ISQ" tool for implant stability, "VAS" scale |
- Primary ISQ: MDM 77.1 (SD 6.9); xenograft 77 (SD 5.9); P = 0.807 - Secondary ISQ after 2 months: MDM 81.8 (SD 5.1); xenograft 80.1 (SD 3.8); P = 0.054 - Percentage of newly formed bone: MDM 47.3 (SD 14.8)%; xenograft 34.9 (SD 13.2)%; P = 0.001 - Percentage of remaining bone substitute: MDM: 12.2 (SD 7.7)%; xenograft: 22.1 (SD 10.9)%; P = 0.001 - Reported pain: MDM: 10/26; xenograft: 10/26; P = 0.904 |
- Hematoma: MDM 26.5%; xenograft 18.8%; P = 0.596 - Dehiscence: MDM 38.2%; xenograft 46.9%; P = 0.549 - Membrane exposure: MDM 11.8%; xenograft 12.5%; P = 0.968 - Graft exposure: MDM 0%; xenograft 0% |
Kim et al. [34] | Maxillary sinus floor lift | Autogenous demineralized dentin (particulate) | Panoramic radiography |
- Vertical bone gain: DDM 4.89 mm; synthetic bone 6.22 mm; P = 0.46 - Bone resorption after 1 year: DDM 0.76 mm; synthetic bone 0.53 mm; P = 0.57 |
Failed osseointegration of one implant in synthetic bone group |
Korsch and Peichl [35] | Lateral alveolar; ridge augmentation | Partially demineralized dentin block (particulate) | CBCT, "Osstell™ ISQ" tool for implant stability |
- ISQ: BST 74.7; TST 73.3 - Horizontal hard tissue loss (after 3months): BST (1 case) 0.5 mm; TST (1 case) 1 mm. - Integrity of the buccal lamella (after 3 months): TST - did not happen in most cases; BST - happen in most cases |
- Wound dehiscences: BST 2 of 31; TST 1 of 28; P = 0.615 - Inflammations: BST 3 of 31; TST: 0 of 28; P = 0.091 |
Xiao et al. [36] | Alveolar bone augmentation | Autogenous dentin (particulate) + xenograft + collagen membrane + CGF | CBCT |
- Vertical bone gain: dentin 2.91 (SD 3.75) mm; bone 2.79 (SD 3.95) mm; P = 0.886 - Vertical bone resorption: dentin 0.94 (SD 1.43) mm; bone 1.72 (SD 0.84) mm; P = 0.114 - Horizontal bone resorption at 2, 4 and 6 mm: Dentin: 2.41 (SD 2.11) mm; bone: 3.79 (SD 2.77) mm; P = 0.431 Dentin: 1.49 (SD 2.41) mm; bone: 1.94 (SD 1.84) mm; P = 0.283 Dentin: 1.2 (SD 153) mm; bone: 1 (SD 0.64) mm; P = 0.664 |
No registered complications |
DDM = demineralized dentin matric; MDM = mineralized dentin matric; TST = tooth-shell technique; BST = bone-shell technique; CBCT = cone-beam computed tomography; ISQ = implant stability quotient. |